Corvus Pharmaceuticals, Inc.
Compounds and methods for modulating interleukin-2-inducible t-cell kinase
Last updated:
Abstract:
Provided herein, inter alia, are methods and compounds for modulating Interleukin-2-inducible T-cell kinase.
Status:
Grant
Type:
Utility
Filling date:
3 Nov 2017
Issue date:
18 May 2021